Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 6:11 pm Purchase | 2024-12-31 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 11,805,301 9.900% | 149,236 (+1.28%) | Filing History |
| 2025-02-14 6:10 pm Unchanged | 2024-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Venrock Healthcare Capital Partners III, L.P. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-02-14 6:09 pm Sale | 2024-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT | Venrock Healthcare Capital Partners III, L.P. | 2,952,371 6.400% | -1,447,629 (-32.90%) | Filing History |
| 2025-02-14 6:08 pm Purchase | 2024-12-31 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III, L.P. | 1,190,340 6.100% | 283,854 (+31.31%) | Filing History |
| 2025-02-14 6:06 pm Unchanged | 2024-12-31 | 13G | Spyre Therapeutics, Inc. SYRE | Venrock Healthcare Capital Partners III, L.P. | 2,685,448 4.600% | 0 (Unchanged) | Filing History |
| 2025-02-14 6:05 pm Unchanged | 2024-12-31 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Healthcare Capital Partners III, L.P. | 3,575,309 4.500% | 0 (Unchanged) | Filing History |
| 2025-02-03 7:43 pm Purchase | 2025-01-30 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 5,012,796 10.100% | 5,012,796 (New Position) | Filing History |
| 2024-12-04 4:15 pm Purchase | 2024-11-26 | 13G | Cidara Therapeutics, Inc. CDTX | Venrock Healthcare Capital Partners III, L.P. | 1,129,097 9.990% | 1,129,097 (New Position) | Filing History |
| 2024-11-14 5:52 pm Purchase | 2024-09-30 | 13G | Zura Bio Limited ZURA | Venrock Healthcare Capital Partners III, L.P. | 6,853,600 9.990% | 453,981 (+7.09%) | Filing History |
| 2024-11-14 5:52 pm Sale | 2024-09-30 | 13G | Viridian Therapeutics, Inc. VRDN | Venrock Healthcare Capital Partners III, L.P. | 3,575,309 5.500% | -1,980,259 (-35.64%) | Filing History |
| 2024-11-14 5:51 pm Sale | 2024-09-30 | 13G | Terns Pharmaceuticals, Inc. TERN | Venrock Healthcare Capital Partners III, L.P. | 3,516,889 4.990% | -980,228 (-21.80%) | Filing History |
| 2024-11-14 5:51 pm Sale | 2024-09-30 | 13G | Taysha Gene Therapies, Inc. TSHA | Venrock Healthcare Capital Partners III, L.P. | 9,000,000 4.400% | -1,412,872 (-13.57%) | Filing History |
| 2024-11-14 5:50 pm Sale | 2024-09-30 | 13G | Spyre Therapeutics, Inc. SYRE | Venrock Healthcare Capital Partners III, L.P. | 2,685,448 5.300% | -1,049,066 (-28.09%) | Filing History |
| 2024-11-14 5:50 pm Purchase | 2024-09-30 | 13G | Praxis Precision Medicines, Inc. PRAX | Venrock Healthcare Capital Partners III, L.P. | 906,486 5.000% | 82,860 (+10.06%) | Filing History |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Oruka Therapeutics, Inc. ORKA | Venrock Healthcare Capital Partners III, L.P. | 3,541,941 9.990% | 3,541,941 (New Position) | Filing History |
| 2024-11-14 5:49 pm Purchase | 2024-09-30 | 13G | Ocular Therapeutix, Inc. OCUL | Venrock Healthcare Capital Partners III, L.P. | 13,760,200 8.700% | 5,984,440 (+76.96%) | Filing History |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | Enliven Therapeutics, Inc. ELVN | Venrock Healthcare Capital Partners III, L.P. | 4,026,331 8.500% | 1,071,429 (+36.26%) | Filing History |
| 2024-11-14 5:48 pm Purchase | 2024-09-30 | 13G | enGene Holdings Inc. Common Stock ENGN | Venrock Healthcare Capital Partners III, L.P. | 3,565,841 8.100% | 1,000,000 (+38.97%) | Filing History |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Applied Therapeutics, Inc. APLT | Venrock Healthcare Capital Partners III, L.P. | 11,656,065 9.990% | 3,778,248 (+47.96%) | Filing History |
| 2024-11-14 5:47 pm Purchase | 2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Venrock Healthcare Capital Partners III, L.P. | 1,744,373 5.900% | 816,667 (+88.03%) | Filing History |